Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.
In: Journal of Crohn's & Colitis, Jg. 16 (2022-10-01), Heft 10, S. 1617-1627
academicJournal
Zugriff:
Background and aims Adherent invasive Escherichia coli [AIEC] are recovered with a high frequency from the gut mucosa of Crohn's disease patients and are believed to contribute to the dysbiosis and pathogenesis of this inflammatory bowel disease. In this context, bacteriophage therapy has been proposed for specifically targeting AIEC in the human gut with no deleterious impact on the commensal microbiota. Methods The in vitro efficacy and specificity of a seven lytic phage cocktail [EcoActive™] was assessed against [i] 210 clinical AIEC strains, and [ii] 43 non- E. coli strains belonging to the top 12 most common bacterial genera typically associated with a healthy human microbiome. These data were supported by in vivo safety and efficacy assays conducted on healthy and AIEC-colonized mice, respectively. Results The EcoActive cocktail was effective in vitro against 95% of the AIEC strains and did not lyse any of the 43 non- E. coli commensal strains, in contrast to conventional antibiotics. Long-term administration of the EcoActive cocktail to healthy mice was safe and did not induce dysbiosis according to metagenomic data. Using a murine model of induced colitis of animals infected with the AIEC strain LF82, we found that a single administration of the cocktail failed to alleviate inflammatory symptoms, while mice receiving the cocktail twice a day for 15 days were protected from clinical and microscopical manifestations of inflammation. Conclusions Collectively, the data support the approach of AIEC-targeted phage therapy as safe and effective treatment for reducing AIEC levels in the gut of IBD patients. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Crohn's & Colitis is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.
|
---|---|
Autor/in / Beteiligte Person: | Titécat, Marie ; Rousseaux, Christel ; Dubuquoy, Caroline ; Foligné, Benoît ; Rahmouni, Oumaïra ; Mahieux, Séverine ; Desreumaux, Pierre ; Woolston, Joelle ; Sulakvelidze, Alexander ; Wannerberger, Kristin ; Neut, Christel |
Zeitschrift: | Journal of Crohn's & Colitis, Jg. 16 (2022-10-01), Heft 10, S. 1617-1627 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1873-9946 (print) |
DOI: | 10.1093/ecco-jcc/jjac064 |
Sonstiges: |
|